Pills masthead

Lannett Company's Chief Executive Officer Receives High Rating

PHILADELPHIA, May 26, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that its chief executive officer, Arthur Bedrosian, received a top rating in a report by Owler, the world's largest community-based business insights platform.  Bedrosian was the fourth highest rated CEO in Philadelphia and 30th among CEOs in the Pharma and Biotech industry. 

Lannett Logo (PRNewsFoto/Lannett Company, Inc.)

Last week, Owler announced the results of its inaugural 2017 Top-Rated CEO Rankings.  The ratings break down the most-liked CEOs from public and private institutions across the county by industry and city.  The report includes all CEOs with 10 or more ratings spanning 50 cities and 25 industries. Employees, followers, competitors and other general users of Owler were asked to rate CEOs. Owler analyzed approval ratings of the top 5,000 most-rated chief executives included their top-rated CEO rankings.

"While we are in the business of bringing high quality, lower cost medications to patients, our industry can be quite competitive, making this recognition from employees and peer companies especially gratifying," said Bedrosian.  "I am honored to be among this list of well-respected CEOs."

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.  For more information, visit the company's website at www.lannett.com.


Robert Jaffe

Robert Jaffe Co., LLC

(424) 288-4098


SOURCE Lannett Company, Inc.

Price Data